BOSTON SCIENTIFIC CORPORATION Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High
BOSTON SCIENTIFIC CORPORATION (BSX) had Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High of $751.00 million as of 2021-06-30, per its 10-Q filed 2021-08-06.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Contingent Consideration
us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh · last filed 2021-08-06
- 2021-06-30: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $751.00M.
- 2021-03-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $754.00M.
- 2020-12-31: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $532.00M.
- 2020-09-30: Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $627.00M.
| Period end | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High as first filed |
|---|---|---|
| 2021-06-30 | $751.00M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $754.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $532.00M 10-K · filed 2021-02-23 | |
| 2020-09-30 | $627.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $627.00M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $658.00M 10-Q · filed 2020-05-06 | |
| 2019-09-30 | $747.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $959.00M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $914.00M 10-Q · filed 2019-04-29 | |
| 2018-09-30 | $780.00M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $1.53B 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $1.32B 10-Q · filed 2018-05-01 | |
| 2017-11-01 | $130.00M 10-Q · filed 2018-07-31 | |
| 2017-09-30 | $1.26B 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.28B 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.28B 10-Q · filed 2017-05-03 | |
| 2016-09-30 | $1.59B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.57B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $1.59B 10-Q · filed 2016-05-04 | |
| 2015-09-30 | $1.89B 10-Q · filed 2015-11-04 | |
| 2012-11-19 | $300.00M 10-K · filed 2015-02-25 | $125.00M 10-K · filed 2013-02-22 |
| 2012-10-08 | $175.00M 10-K · filed 2015-02-25 | |
| 2012-10-04 | $90.00M 10-K · filed 2015-02-25 | |
| 2012-09-30 | $1.93B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.90B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $730.00M 10-Q · filed 2012-05-03 | |
| 2011-03-31 | $260.00M 10-Q · filed 2011-05-05 | |
| 2010-12-31 | $260.00M 10-K · filed 2011-02-17 | |
| 2010-11-03 | $24.00M 8-K · filed 2013-05-29 | |
| 2010-10-26 | $250.00M 8-K · filed 2013-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |